Director, Cardiovascular Intensive Care Unit and Critical Care Echocardiography
Vanderbilt University Medical Center
Nashville, Tennessee
Antonio Hernandez, MD, MSc, FCCM, FASE
Professor of Anesthesiology
Biographical Sketch
Dr. Antonio Hernandez develops new therapies to enhance innate immunity antimicrobial function and protect against inflammation-induced organ injury. His research includes the study of trained immunity to alter the inflammatory response to infection or injury and has focused on synthetic de novo vaccine adjuvants which are candidates for pharmaceutical development for human use. He employs clinically relevant models of acute sepsis, sepsis-induced immunosuppression, and ischemia reperfusion injury where he has trained the innate immune system to enhance antimicrobial function and reduce organ injury.
Dr. Hernandez received his Bachelors of Science in biology with honors from the University of Texas at El Paso and his Medical Doctorate from the University of Texas Medical Branch at Galveston. After completing an anesthesiology residency at the University of Texas Medical Branch at Galveston, he remained there to complete fellowships in Anesthesiology Critical Care Medicine followed by Cardiothoracic Anesthesiology. He was appointed to the faculty at Vanderbilt University where he also received his Masters of Science in Clinical Investigation. In addition to his research, Dr. Hernandez directs the cardiovascular intensive care unit where he has built perioperative support services for advanced care programs, including total artificial heart, pulmonary endarterectomy, combined heart-lung, and heart-liver transplantation, and ECMO.
Thursday, January 19, 2023
7:00 AM – 5:30 PM PT
Disclosure(s): No relevant financial relationship(s) to disclose.
Friday, January 20, 2023
7:00 AM – 12:30 PM PT
Disclosure(s): No relevant financial relationship(s) to disclose.
Friday, January 20, 2023
7:00 AM – 5:30 PM PT
Disclosure(s): No relevant financial relationship(s) to disclose.
Friday, January 20, 2023
11:30 AM – 5:30 PM PT
Disclosure(s): No relevant financial relationship(s) to disclose.
Tuesday, January 24, 2023
9:35 AM – 9:50 AM PT
Disclosure(s): No relevant financial relationship(s) to disclose.